Alteration of pharmacokinetics and nephrotoxicity of cisplatin by alginates

Journal of Pharmaceutical Sciences

Volumn 86, Issue 2, 1997, Pages 244-247

  Imai, T ^a   Fujii, K ^a   Shiraishi, S ^a   Otagiri, M ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CISPLATIN; PLASMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; COMPLEX FORMATION; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; MALE; MOLECULAR WEIGHT; MOUSE; NEPHROTOXICITY; NONHUMAN; PLASMA CLEARANCE; RAT; TUMOR CELL LINE; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION;

EID: 0031047820     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js9601997     Document Type: Article

References (25)

1. Cisplatin: Current Status and New Developments; Prestayko, A. W.; Crooke, S. T.; Carter, S. K.; Eds.; Academic: New York, 1980.
2. Loehrer, P. J.; Einhorn, L. H. Ann. Intern. Med. 1984, 100, 704-713.
3. Gandara, D. R.; Perez, E. A.; Phillips, W. A.; Lawrence, H. J.; DeGegorio, M. Anticancer Res. 1989, 9, 1121-1128.
4. Meyer, K. B.; Madias, N. E. Miner. Electrolyte Metab. 1994, 20, 201-213.
5. Safirstein, R.; Winston, J.; Moel, D.; Dikman, S.; Guttenplan, J. Int. J. Androl. 1987, 10, 325-346.
6. Sobrego, A.; Guglielmi, A.; Aschele, C.; Rosso, R. J. Chemother. 1990, 2, 3-7.
7. Schroyens, W. A.; Meeker, J. B.; Dodion, P.; Stryckmans, P. A.; Rozencweig, M. Eur. J. Cancer Clin. Oncol. 1988, 24, 1309-1312.
8. Pinzani, V.; Bressolle, F.; Haug, I. J.; Galtier, M.; Blayac, J. P.; Balmes, P. Cancer Chemother. Pharmacol. 1994, 35, 1-9.
9. Jones, M. M.; Basinger, M. A.; Holscher, M. A. Toxicology 1991, 68, 227-247.
10. Goel, R.; Cleary, S. M.; Horton, C.; Kirmani, S.; Abramason, I.; Kelly, C.; Howell, S. B. J. Natl. Cancer Inst. 1989, 81, 1552-1560.
11. Berry, J. M.; Jacobs, C.; Sikie, B.; Halsey, J.; Borch, R. F. J. Clin. Oncol. 1990, 8, 1585-1590.
12. Baldew, G. S.; Mcvie, J. G.; Van der Valk, M. A.; Los, G.; De Goeij, J. J. M.; Vermeulen, N. P. E. Cancer Res. 1990, 50, 7031-7036.
13. Sugawara, S.; Imai, T.; Otagiri, M. Pharm. Res. 1994, 11, 272-277.
14. Penman, A.; Sanderson, G. R. Carbohydr. Res. 1972, 16, 273-282.
15. LeRoy, A. F.; Wehling, M. L.; Sponseller, H. L.; Friauf, W. S.; Solomon, R. E., Dedrick, R. L.; Litterst, C. L.; Gram, T. E.; Guarino, A. M.; Becker, D. A. Biochem. Med. 1977, 18, 184-191.
16. Yamaoka, K.; Tanigawara, Y.; Nakagawa, T.; Uno, T. J. Pharmacobio-Dyn. 1981, 4, 879-885.
17. Carmichael, J.; DeGraff, W. G.; Gazdar, A. F.; Minna, J. D.; Michell, J. B. Cancer Res. 1987, 47, 936-942.
18. Siddik, Z. H.; Newell, D. R.; Boxall, F. E.; Harrap, K. R. Biochem. Pharmacol. 1987, 36, 1925-1932.
19. Farris, F. F.; King, F. G.; Dedrick, R. L.; Littersst, C. L. J. Pharmacokinet. Biopharm. 1985, 13, 13-39.
20. Daugaard, G. Dan. Med. Bull. 1990, 37, 1-12.
21. Jeffay, H.; Winzler, R. J. Biol. Chem. 1958, 231, 1010-1110.
22. Laznickova, A.; Filipova, M.; Laznicek, M.; Drobnik, J.; Svoboda, D.; Kvetina, J. Neoplasma 1987, 34, 173-181.
23. Argent, N. B.; Liles, J.; Rodham, D.; Clayton, C. B.; Wilkinson, R.; Baylis, P. H. Lab. Animals 1994, 28, 172-175.
24. Daley-Yates, P. T.; McBrien, D. C. H. Biochem. Pharmacol. 1982, 31, 2243-2246.
25. Daugaard, G.; Abildgaard, U.; Holstein-Rathlou, N. H.; Leyssac, P. P.; Amtorp, O.; Dikhoff, T. G. Renal Physiol. 1986, 9, 308-316.